Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New phone therapy aims to ease anxiety in older cancer patients

NCT ID NCT03168971

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a telephone-based therapy called Managing Anxiety from Cancer (MAC) for older adults (65+) with cancer and their caregivers. The therapy includes seven sessions covering relaxation, communication, and problem-solving skills. The goal was to see if it reduces anxiety better than usual care. Only 26 people took part, so results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Managing Anxiety from Cancer (MAC) therapy (telephone-administered psychological intervention)
What this could lead to
If it works, this could provide a practical, home-based therapy to reduce anxiety and improve quality of life for older cancer patients and their caregivers.
What could go wrong
This is a very small pilot study with only 26 participants, so results may not apply to everyone. The therapy is still experimental and may not be more effective than usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

Jan 2019

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: PATIENTS: * Age 65 or older * Confirmed diagnosis of breast, lymphoma, genitourinary, thoracic, gynecological or gastrointestinal cancer, currently on active treatment or within six months of completion of treatment * As determined by the patient's primary oncologist and/or study staff, physically and cognitively able to complete study procedures * English fluent (as per self-reported fluency of "very well")\*\* * In the judgment of the investigators and/or consenting professional, able to perform informed consent * Has a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) who is willing and able to participate in the study * As part of the patient-caregiver dyad, at least one member reports elevated anxiety as defined by a score of 8 or greater on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) * As per self-report, residency in New York or ability to complete sessions in New York * Able to communicate over the phone for sessions * Willingness to be audio-recorded for assessments and, if applicable, study sessions CAREGIVERS: * Age 21 or older * In the judgment of the investigators and/or consenting professional, able to perform informed consent * As part of the patient-caregiver dyad, at least one member reports elevated anxiety as defined by a score of 8 or greater on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) * English fluent (as per self-reported fluency of "very well")\*\* * Is a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) for an MSK patient * As per self-report, residency in New York or ability to complete sessions in New York * Able to communicate over the phone for sessions * Willingness to be audio-recorded for assessments and, if applicable, study sessions Exclusion Criteria: PATIENTS: * Endorsing active suicidal ideation on the item, "In light of your current circumstances, have you ever had thoughts of killing yourself?" * As per oncologist or self-report, too weak or cognitively impaired to participate in the intervention and complete the assessments * Per self-report/screening measures, has received cognitive-behavioral therapy since cancer diagnosis * As per medical record or self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder * Anxiety due solely to a medical procedure as determined by a patient-report item on the screening questionnaire CAREGIVERS: * Endorsing active suicidal ideation on the item, "In light of your current circumstances, have you ever had thoughts of killing yourself?" * Per self-report/screening measures, has received cognitive-behavioral therapy since patient"s cancer diagnosis * As per self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder * If female, currently pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.